Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
47%
OVERLAP
BY WEIGHT
103
# OF OVERLAPPING
HOLDINGS
IBB
256
HOLDINGS
47%
ALSO IN XBI
XBI
118
HOLDINGS
89%
ALSO IN IBB
SECTOR DRIFT (IBB minus XBI)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IBB |
Weight in XBI |
Overlap | |
---|---|---|---|---|
REGENERON PHARMACEUTICALS | 6.7% | 2.6% | 2.6% | |
ALNYLAM PHARMACEUTICALS INC | 4.5% | 2.5% | 2.5% | |
VERTEX PHARMACEUTICALS INC | 7.9% | 2.4% | 2.4% | |
AMGEN INC | 7.6% | 2.4% | 2.4% | |
GILEAD SCIENCES INC | 7.4% | 2.4% | 2.4% |
IBB Overweight Relative to XBI
VERTEX PHARMACEUTICALS INC | 5.4% | |
AMGEN INC | 5.2% | |
GILEAD SCIENCES INC | 5.0% | |
REGENERON PHARMACEUTICALS | 4.1% | |
IQVIA HOLDINGS INC | 3.2% | |
METTLER-TOLEDO INTERNATIONAL | 2.9% | |
ARGENX SE ADR | 2.4% | |
WATERS CORP | 2.4% | |
ALNYLAM PHARMACEUTICALS INC | 2.0% | |
BIONTECH SE SPONSORED ADR | 1.9% |
IBB Underweight Relative to XBI
ABBVIE INC | -2.4% | |
EXACT SCIENCES CORP | -2.2% | |
TG THERAPEUTICS INC | -1.7% | |
HALOZYME THERAPEUTICS INC | -1.7% | |
MODERNA, INC. | -1.5% | |
BRIDGEBIO PHARMA, INC. | -1.4% | |
EXELIXIS INC | -1.2% | |
VIKING THERAPEUTICS, INC. | -1.2% | |
MADRIGAL PHARMACEUTICALS, INC. | -1.2% | |
BIOMARIN PHARMACEUTICAL INC | -1.1% |